Administrative and Statistics Support for Cancer Drug Discovery
Core A -Administrative & Biostatistics Core
This program supports teams working to find new cancer medicines from plants, lichens, cyanobacteria, and fungi for people with tumors that don't respond to current treatments.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-11198504 on NIH RePORTER |
What this research studies
From a patient's view, this core brings together researchers at multiple universities to speed discovery of new anti-cancer compounds sourced from plants and microbes. The core runs the administrative side of the program, managing budgets, sharing information, and coordinating collaboration across projects. It also provides biostatistics and study-design support so experiments and early testing produce reliable results. By integrating projects and services, the core aims to move promising compounds more efficiently toward further development.
Who could benefit from this research
Good fit: Patients with cancers that are resistant to standard therapies could eventually become candidates for treatments developed by teams supported by this program.
Not a fit: People without cancer or with tumors already well controlled by existing treatments are unlikely to see a direct benefit from this administrative and statistics core.
Why it matters
Potential benefit: If successful, the program could lead to new chemotherapy options for tumors that are not cured by current treatments.
How similar studies have performed: Natural-product drug discovery has produced important cancer drugs in the past, but each new compound requires extensive testing before it can help patients.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Kinghorn, Alan Douglas — Ohio State University
- Study coordinator: Kinghorn, Alan Douglas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.